CN Stock MarketDetailed Quotes

001328 Dencare

Watchlist
  • 33.20
  • +1.70+5.40%
Market Closed Dec 20 15:00 CST
5.72BMarket Cap37.73P/E (TTM)

Dencare Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
4.12%1.05B
5.45%703.13M
5.22%360.56M
4.76%1.38B
3.58%1.01B
9.19%666.82M
10.65%342.67M
14.95%1.31B
976.29M
610.69M
Operating revenue
4.12%1.05B
5.45%703.13M
5.22%360.56M
4.76%1.38B
3.58%1.01B
9.19%666.82M
10.65%342.67M
14.95%1.31B
--976.29M
--610.69M
Other operating revenue
----
-26.38%1.07M
----
-1.92%2.22M
----
55.11%1.45M
----
-6.28%2.26M
----
--935.57K
Total operating cost
4.84%944.83M
5.87%637.06M
6.53%325.4M
5.62%1.26B
3.91%901.2M
10.23%601.73M
10.73%305.46M
16.04%1.19B
867.29M
545.9M
Operating cost
-5.33%534.31M
-2.18%373.13M
-7.62%185.94M
-1.59%768.96M
-1.32%564.41M
7.25%381.44M
9.57%201.28M
18.13%781.39M
--571.93M
--355.65M
Operating tax surcharges
5.53%6.82M
8.04%4.2M
-21.39%1.77M
3.19%9.08M
21.35%6.46M
27.13%3.89M
161.19%2.25M
-9.69%8.8M
--5.32M
--3.06M
Operating expense
24.17%329.3M
21.47%212.07M
44.88%114.45M
22.51%386.29M
13.90%265.2M
15.33%174.58M
8.55%79M
12.86%315.32M
--232.83M
--151.38M
Administration expense
-0.03%44.08M
-4.80%28.76M
-2.53%13.72M
23.26%66.9M
12.95%44.1M
17.23%30.21M
14.93%14.07M
12.25%54.28M
--39.04M
--25.77M
Financial expense
34.16%-8.04M
24.91%-6.19M
-103.55%-3.53M
-73.67%-16.85M
-51.93%-12.21M
-13.15%-8.24M
37.95%-1.73M
-10.83%-9.7M
---8.04M
---7.28M
-Interest expense (Financial expense)
-15.49%900K
-15.49%600K
-15.49%300K
-23.79%1.42M
-7.32%1.06M
-9.10%710K
12.86%355K
-6.52%1.86M
--1.15M
--781.08K
-Interest Income (Financial expense)
32.51%-9.02M
24.06%-6.84M
-81.81%-3.85M
-57.12%-18.39M
-43.75%-13.37M
-10.65%-9.01M
32.75%-2.12M
-7.49%-11.71M
---9.3M
---8.15M
Research and development
15.36%38.37M
26.42%25.09M
23.18%13.05M
6.47%42.73M
26.90%33.26M
14.56%19.84M
16.91%10.59M
13.00%40.13M
--26.21M
--17.32M
Credit Impairment Loss
-44.87%225.35K
125.95%32.97K
-759.33%-397.9K
99.25%-5.73K
137.28%408.78K
79.21%-127.01K
73.88%60.35K
-216.20%-762.08K
---1.1M
---610.86K
Asset Impairment Loss
44.57%-4.21M
2.12%-5.39M
7.81%-3.66M
34.91%-2.88M
4.69%-7.6M
-17.02%-5.5M
-5.11%-3.97M
22.14%-4.43M
---7.97M
---4.7M
Other net revenue
93.23%29.04M
85.85%17.65M
5,402.69%8.18M
32.52%28.78M
8.91%15.03M
286.81%9.5M
115.97%148.57K
12.51%21.72M
13.8M
2.46M
Fair value change income
-87.65%739.45K
225.37%4.17M
229.40%2.89M
10,637.40%11.1M
281.27%5.99M
21.67%1.28M
--878.83K
-83.74%103.33K
--1.57M
--1.05M
Invest income
1,321.49%18.57M
574.40%8.81M
525.43%3.57M
-47.07%1.62M
54.17%1.31M
146.26%1.31M
12.35%570.43K
-67.84%3.06M
--847.27K
--530.43K
Net open hedge income
----
----
----
----
----
--0
----
----
----
----
-Including: Investment income associates
----
----
----
----
----
--0
----
----
----
----
Asset deal income
----
----
----
----
-101.69%-9.05K
-101.69%-9.05K
---9.05K
--613.1K
--534.4K
--534.4K
Other revenue
-8.13%13.72M
-20.09%10.03M
120.36%5.77M
-18.06%18.95M
-25.02%14.93M
122.08%12.55M
13.62%2.62M
53.38%23.13M
--19.92M
--5.65M
Operating profit
9.63%137.12M
12.24%83.73M
16.00%43.33M
1.81%147.46M
1.86%125.08M
10.92%74.59M
13.55%37.36M
6.42%144.83M
122.8M
67.25M
Add:Non operating Income
-46.66%372.02K
-66.34%200.55K
-81.95%48.65K
1,142.63%13.58M
-22.64%697.45K
-3.08%595.87K
-0.93%269.45K
169.23%1.09M
--901.54K
--614.8K
Less:Non operating expense
1,134.14%225.79K
616,891.52%24.74K
369,376.31%14.82K
29.41%217.65K
-87.22%18.3K
-99.99%4.01
--4.01
-90.49%168.19K
--143.19K
--43.19K
Total profit
9.16%137.27M
11.59%83.9M
15.25%43.37M
10.33%160.82M
1.78%125.76M
10.86%75.19M
13.43%37.63M
8.18%145.76M
123.55M
67.82M
Less:Income tax cost
6.89%19.33M
24.56%11.49M
13.18%6.05M
75.16%19.52M
2.02%18.09M
-4.87%9.22M
12.75%5.35M
-29.78%11.14M
--17.73M
--9.69M
Net profit
9.54%117.94M
9.77%72.42M
15.60%37.32M
4.97%141.3M
1.74%107.67M
13.48%65.97M
13.54%32.28M
13.25%134.61M
105.82M
58.13M
Net profit from continuing operation
9.54%117.94M
9.77%72.42M
15.60%37.32M
4.97%141.3M
1.74%107.67M
13.48%65.97M
13.54%32.28M
13.25%134.61M
--105.82M
--58.13M
Net profit of parent company owners
9.54%117.94M
9.77%72.42M
15.60%37.32M
4.97%141.3M
1.74%107.67M
13.48%65.97M
13.54%32.28M
13.25%134.61M
--105.82M
--58.13M
Earning per share
Basic earning per share
0.41%0.685
-4.55%0.42
-12.00%0.22
-15.38%0.88
-16.75%0.6822
-2.27%0.44
13.64%0.25
13.04%1.04
--0.8195
--0.4502
Diluted earning per share
0.41%0.685
-4.55%0.42
-12.00%0.22
-15.38%0.88
-16.75%0.6822
-2.27%0.44
13.64%0.25
13.04%1.04
--0.8195
--0.4502
Other composite income
-156.25%-820K
-111.47%-320K
Other composite income of parent company owners
----
----
----
-156.25%-820K
----
----
----
-111.47%-320K
----
----
Total composite income
9.54%117.94M
9.77%72.42M
15.60%37.32M
4.61%140.48M
1.74%107.67M
13.48%65.97M
13.54%32.28M
10.39%134.29M
105.82M
58.13M
Total composite income of parent company owners
9.54%117.94M
9.77%72.42M
15.60%37.32M
4.61%140.48M
1.74%107.67M
13.48%65.97M
13.54%32.28M
10.39%134.29M
--105.82M
--58.13M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 4.12%1.05B5.45%703.13M5.22%360.56M4.76%1.38B3.58%1.01B9.19%666.82M10.65%342.67M14.95%1.31B976.29M610.69M
Operating revenue 4.12%1.05B5.45%703.13M5.22%360.56M4.76%1.38B3.58%1.01B9.19%666.82M10.65%342.67M14.95%1.31B--976.29M--610.69M
Other operating revenue -----26.38%1.07M-----1.92%2.22M----55.11%1.45M-----6.28%2.26M------935.57K
Total operating cost 4.84%944.83M5.87%637.06M6.53%325.4M5.62%1.26B3.91%901.2M10.23%601.73M10.73%305.46M16.04%1.19B867.29M545.9M
Operating cost -5.33%534.31M-2.18%373.13M-7.62%185.94M-1.59%768.96M-1.32%564.41M7.25%381.44M9.57%201.28M18.13%781.39M--571.93M--355.65M
Operating tax surcharges 5.53%6.82M8.04%4.2M-21.39%1.77M3.19%9.08M21.35%6.46M27.13%3.89M161.19%2.25M-9.69%8.8M--5.32M--3.06M
Operating expense 24.17%329.3M21.47%212.07M44.88%114.45M22.51%386.29M13.90%265.2M15.33%174.58M8.55%79M12.86%315.32M--232.83M--151.38M
Administration expense -0.03%44.08M-4.80%28.76M-2.53%13.72M23.26%66.9M12.95%44.1M17.23%30.21M14.93%14.07M12.25%54.28M--39.04M--25.77M
Financial expense 34.16%-8.04M24.91%-6.19M-103.55%-3.53M-73.67%-16.85M-51.93%-12.21M-13.15%-8.24M37.95%-1.73M-10.83%-9.7M---8.04M---7.28M
-Interest expense (Financial expense) -15.49%900K-15.49%600K-15.49%300K-23.79%1.42M-7.32%1.06M-9.10%710K12.86%355K-6.52%1.86M--1.15M--781.08K
-Interest Income (Financial expense) 32.51%-9.02M24.06%-6.84M-81.81%-3.85M-57.12%-18.39M-43.75%-13.37M-10.65%-9.01M32.75%-2.12M-7.49%-11.71M---9.3M---8.15M
Research and development 15.36%38.37M26.42%25.09M23.18%13.05M6.47%42.73M26.90%33.26M14.56%19.84M16.91%10.59M13.00%40.13M--26.21M--17.32M
Credit Impairment Loss -44.87%225.35K125.95%32.97K-759.33%-397.9K99.25%-5.73K137.28%408.78K79.21%-127.01K73.88%60.35K-216.20%-762.08K---1.1M---610.86K
Asset Impairment Loss 44.57%-4.21M2.12%-5.39M7.81%-3.66M34.91%-2.88M4.69%-7.6M-17.02%-5.5M-5.11%-3.97M22.14%-4.43M---7.97M---4.7M
Other net revenue 93.23%29.04M85.85%17.65M5,402.69%8.18M32.52%28.78M8.91%15.03M286.81%9.5M115.97%148.57K12.51%21.72M13.8M2.46M
Fair value change income -87.65%739.45K225.37%4.17M229.40%2.89M10,637.40%11.1M281.27%5.99M21.67%1.28M--878.83K-83.74%103.33K--1.57M--1.05M
Invest income 1,321.49%18.57M574.40%8.81M525.43%3.57M-47.07%1.62M54.17%1.31M146.26%1.31M12.35%570.43K-67.84%3.06M--847.27K--530.43K
Net open hedge income ----------------------0----------------
-Including: Investment income associates ----------------------0----------------
Asset deal income -----------------101.69%-9.05K-101.69%-9.05K---9.05K--613.1K--534.4K--534.4K
Other revenue -8.13%13.72M-20.09%10.03M120.36%5.77M-18.06%18.95M-25.02%14.93M122.08%12.55M13.62%2.62M53.38%23.13M--19.92M--5.65M
Operating profit 9.63%137.12M12.24%83.73M16.00%43.33M1.81%147.46M1.86%125.08M10.92%74.59M13.55%37.36M6.42%144.83M122.8M67.25M
Add:Non operating Income -46.66%372.02K-66.34%200.55K-81.95%48.65K1,142.63%13.58M-22.64%697.45K-3.08%595.87K-0.93%269.45K169.23%1.09M--901.54K--614.8K
Less:Non operating expense 1,134.14%225.79K616,891.52%24.74K369,376.31%14.82K29.41%217.65K-87.22%18.3K-99.99%4.01--4.01-90.49%168.19K--143.19K--43.19K
Total profit 9.16%137.27M11.59%83.9M15.25%43.37M10.33%160.82M1.78%125.76M10.86%75.19M13.43%37.63M8.18%145.76M123.55M67.82M
Less:Income tax cost 6.89%19.33M24.56%11.49M13.18%6.05M75.16%19.52M2.02%18.09M-4.87%9.22M12.75%5.35M-29.78%11.14M--17.73M--9.69M
Net profit 9.54%117.94M9.77%72.42M15.60%37.32M4.97%141.3M1.74%107.67M13.48%65.97M13.54%32.28M13.25%134.61M105.82M58.13M
Net profit from continuing operation 9.54%117.94M9.77%72.42M15.60%37.32M4.97%141.3M1.74%107.67M13.48%65.97M13.54%32.28M13.25%134.61M--105.82M--58.13M
Net profit of parent company owners 9.54%117.94M9.77%72.42M15.60%37.32M4.97%141.3M1.74%107.67M13.48%65.97M13.54%32.28M13.25%134.61M--105.82M--58.13M
Earning per share
Basic earning per share 0.41%0.685-4.55%0.42-12.00%0.22-15.38%0.88-16.75%0.6822-2.27%0.4413.64%0.2513.04%1.04--0.8195--0.4502
Diluted earning per share 0.41%0.685-4.55%0.42-12.00%0.22-15.38%0.88-16.75%0.6822-2.27%0.4413.64%0.2513.04%1.04--0.8195--0.4502
Other composite income -156.25%-820K-111.47%-320K
Other composite income of parent company owners -------------156.25%-820K-------------111.47%-320K--------
Total composite income 9.54%117.94M9.77%72.42M15.60%37.32M4.61%140.48M1.74%107.67M13.48%65.97M13.54%32.28M10.39%134.29M105.82M58.13M
Total composite income of parent company owners 9.54%117.94M9.77%72.42M15.60%37.32M4.61%140.48M1.74%107.67M13.48%65.97M13.54%32.28M10.39%134.29M--105.82M--58.13M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Medical Device Concept
Medical Device Concept
Intraday+0.57%